Peer-influenced content. Sources you trust. No registration required. This is HCN.
NEJM Evidence
Explore how the persistence of detectable Epstein-Barr virus DNA can serve as a significant predictive marker for nasopharyngeal cancer, potentially revolutionizing early diagnosis and improving survival rates.
Oncology, Medical July 3rd 2023
Cancer Therapy Advisor
The study findings suggest that acalabrutinib and rituximab, a chemo-free therapy option, may offer a new standard of care for older, untreated MCL patients, with promising early complete responses. Yet, more data is needed to understand long-term safety and risk of relapse.
Hematology/Oncology July 3rd 2023
Medical Professionals Reference (MPR)
Discover the potential of xanthine dehydrogenase/oxidase blockers, such as allopurinol, in reducing the risk of neurodegenerative diseases. This large-scale study reveals intriguing associations and sets the stage for future research.
Clinical Pharmacology June 30th 2023
The New England Journal of Medicine
Findings from this trial may reshape how physicians perceive and prescribe testosterone-replacement therapy for middle-aged and older men with hypogonadism, with no substantial rise in major adverse cardiac events reported.
Cardiology June 29th 2023
Psychiatrist.com
Explore the results of this study, which shed light on the underreported and frequently misunderstood phenomena of “brain zaps” during antidepressant withdrawal and its effects on medicine use and quality of life.
Psychiatry June 28th 2023
Practical Neurology
Explore the findings of a retrospective study examining treatment persistence in migraine patients using CGRP mAb therapies or Botox – the results may surprise you.
Neurology June 28th 2023